(Q44021835)

29 November 2017

title

Immunotherapy for murine K1735 melanoma: combinatorial use of recombinant adenovirus expressing CD40L and other immunomodulators (English)

1 reference

29 November 2017

1 reference

1 reference

Isabelle Peter

1

1 reference

29 November 2017

Michael Nawrath

2

1 reference

29 November 2017

Jivko Kamarashev

3

1 reference

29 November 2017

Bernhard Odermatt

4

1 reference

29 November 2017

Anna Mezzacasa

5

1 reference

29 November 2017

Silvio Hemmi

6

1 reference

29 November 2017

publication date

1 July 2002

1 reference

29 November 2017

1 reference

29 November 2017

volume

9

1 reference

29 November 2017

issue

7

1 reference

29 November 2017

page(s)

597-605

1 reference

29 November 2017

cites work

Cancer statistics, 1998.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700475

Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700475

Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700475

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700475

Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700475

Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700475

Immunological gene therapy with ex vivo gene-modified tumor cells: a critique and a reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700475

Dendritic cells and the control of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700475

Antitumor responses induced by transgenic expression of CD40 ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700475

In vivo gene transfer of CD40 ligand into colon cancer cells induces local production of cytokines and chemokines, tumor eradication and protective antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700475

Adenovirus-mediated gene transfer into monocyte-derived macrophages of patients with X-linked chronic granulomatous disease: ex vivo correction of deficient respiratory burst

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700475

Therapy of tuberculosis in mice by DNA vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700475

Cancer vaccines: the interleukin 2 dosage effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700475

Activation of human dendritic cells through CD40 cross-linking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700475

Comparative analysis of immunocritical melanoma markers in the mouse melanoma cell lines B16, K1735 and S91-M3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700475

Gene transfer of GM-CSF, CD80 and CD154 cDNA enhances survival in a murine model of acute leukemia with persistence of a minimal residual disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700475

Therapeutic vaccination for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700475

Expression of co-stimulatory molecules by tumor cells decreases tumorigenicity but may also reduce systemic antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700475

Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700475

GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700475

Tumor antigens recognized by T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700475

7 January 2021

Anti-tumor immunity induced by in vivo adenovirus vector-mediated expression of CD40 ligand in tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700475

7 January 2021

T-helper- and accessory-cell-independent cytotoxic responses to human tumor cells transfected with a B7 retroviral vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700475

7 January 2021

The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700475

7 January 2021

Phase I study of recombinant human CD40 ligand in cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700475

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700475

1 reference

Dimensions Publication ID

29 November 2017

1027323780

0 references

1 reference